Peter Collins

Vp, Global Program Team Lead - Neurodegeneration Franchise at Annexon Biosciences

Peter Collins has a diverse and extensive work experience in the pharmaceutical and biotech industry.

Peter is currently working at Annexon Biosciences as the VP, Global Program Team Lead - Neurodegeneration Franchise. Prior to this, they had a significant tenure at BridgeBio, where they held various roles including Vice President, Program Management at Origin Biosciences and ML Bio Solutions, Executive Director, Program Management at Origin and MLBioSolutions, and Director, Program Management at Origin Biosciences.

Before joining BridgeBio, Peter worked at Ultragenyx Pharmaceutical Inc. as an Associate Director, Program and Portfolio Management, and later as a Senior Program Manager, Program and Portfolio Management.

Peter also gained valuable experiences at BioMarin Pharmaceutical Inc., where they served as a Senior Manager, Development Sciences Project Management and Project Manager, Development Sciences.

Earlier in their career, Peter worked at Johnson and Johnson (Janssen Alzheimer Immunotherapy) as a Project Manager, Biomarkers, Clinical Development, and at CCBR Synarc as a Senior Clinical Operations Associate-Supervisor and a Senior Clinical Operations Associate.

Peter'scareer began at Stanford University, where they worked as a Neurocognitive Psychopharmacological Lab Research Assistant, conducting research on white matter hyperintensities and geriatric neuropathologies.

Peter also had roles at CCBR Synarc as a Clinical Operations Associate and at Veteran Affairs Palo Alto Health Care Systems as a VAPAHCS Psychiatric ward research assistant, providing support on multiple Alzheimer's studies.

Overall, Peter Collins has a wealth of experience in program management, project management, and clinical operations within the pharmaceutical and biotech industry.

Peter Collins attended the University of California, Berkeley from 2003 to 2007, where they obtained a B.A. and a Baccalaureate Diploma in the field of Neurosciences and Psychology. Before that, they also completed the International Baccalaureate Diploma, though the specific dates or details were not provided.

Links

Previous companies

BridgeBio logo